Silodosin, a prescription medicine used to treat an enlarged prostate, can prolong the length of time it takes to ejaculate, a study conducted by Stephen Yang (楊緒棣), surgeon-in-chief at Buddhist Tzu Chi General Hospital’s Taipei Branch, has suggested.
The study involved 26 sexually active patients who had taken Silodosin for the treatment of benign prostatic hyperplasia over the period of six-and-a-half months.
The results showed that average intravaginal ejaculation latency time (IELT), which means the time between the start of vaginal intromission and the start of intravaginal ejaculation, in men who took the drug increased from four minutes to 5 minutes, 48 seconds, with seven men saying their IELT was greatly extended, while eight men said they felt no significant difference.
The average age of the patients was 56 years old.
In Taiwan, one in every two men aged 50 or older has an enlarged prostate, Yang said.
Silodosin is also said to work for younger men.
In one study conducted in Japan, eight men in their 30s who suffered from premature ejaculation reported that their average IELT increased from three minutes to 10 minutes, with six saying the improvement was “significant,” Yang said.
Yang’s study also suggests the drug works better for those who suffer from premature ejaculation, extending their IELT from 1 minute, 30 seconds to three minutes.
The average time for those without the problem increases from five minutes to 6 minutes, 48 seconds, he said.
Yang said it is clinically understood that a premature ejaculation happens less than two minutes after penetration, while the IELT needs to be three minutes or longer for women to “feel satisfied.”
The physician said he was interested in looking into the effects of the drug after hearing the reactions of patients who had taken it.
“One day, a woman came in with her 65-year-old husband and asked what kind of medicine I had prescribed him because it made him able to have sex for 30 minutes. Soon the same thing happened with another patient who was 63 years old. Then I knew something was not right,” said Yang, who is also a professor of urology at Tzu Chi University in Hualien City.
Having been developed and received its first marketing approval in Japan in 2006, Silodosin has been available in Taiwan since last year.
Another interesting finding, Yang said, is that the drug provides evidence that the male orgasm is not necessarily connected with the occurrence of ejaculation.
As Silodosin has the ability to block seminal vesicles from secreting and thus preventing the release of semen, half of the patients in the study had no ejaculation, while 47 percent had a decreased sperm count.
However, 97 percent of the subjects reported having an orgasm.
Citing studies conducted in Japan, Yang said Silodosin is completely effective in inhibiting ejaculation as no sperm is detected in the samples provided by volunteers in the studies.
“The drug has the potential to be used as a means of male birth control, but we also need to understand that younger men have a different perception of sex than older men,” the researcher said.
“To them, it is psychologically important to have an ejaculation,” he said.
Both medical studies and clinical experience show that the effect of inhibiting ejaculation is reversible.
Patients can resume the normal ejaculatory function after they stop taking Silodosin for two to three days, Yang said.
Yang and his team are planning to undertake a large-scale research project on Silodosin and expect to publish the results in March next year.
“This particular medicine is very unique, and it has been generating more and more interest,” Yang said.
“I believe we will find out more about its applications in the next few years,” he added.
Former Czech Republic-based Taiwanese researcher Cheng Yu-chin (鄭宇欽) has been sentenced to seven years in prison on espionage-related charges, China’s Ministry of State Security announced yesterday. China said Cheng was a spy for Taiwan who “masqueraded as a professor” and that he was previously an assistant to former Cabinet secretary-general Cho Jung-tai (卓榮泰). President-elect William Lai (賴清德) on Wednesday last week announced Cho would be his premier when Lai is inaugurated next month. Today is China’s “National Security Education Day.” The Chinese ministry yesterday released a video online showing arrests over the past 10 years of people alleged to be
THE HAWAII FACTOR: While a 1965 opinion said an attack on Hawaii would not trigger Article 5, the text of the treaty suggests the state is covered, the report says NATO could be drawn into a conflict in the Taiwan Strait if Chinese forces attacked the US mainland or Hawaii, a NATO Defense College report published on Monday says. The report, written by James Lee, an assistant research fellow at Academia Sinica’s Institute of European and American Studies, states that under certain conditions a Taiwan contingency could trigger Article 5 of NATO, under which an attack against any member of the alliance is considered an attack against all members, necessitating a response. Article 6 of the North Atlantic Treaty specifies that an armed attack in the territory of any member in Europe,
LIKE FAMILY: People now treat dogs and cats as family members. They receive the same medical treatments and tests as humans do, a veterinary association official said The number of pet dogs and cats in Taiwan has officially outnumbered the number of human newborns last year, data from the Ministry of Agriculture’s pet registration information system showed. As of last year, Taiwan had 94,544 registered pet dogs and 137,652 pet cats, the data showed. By contrast, 135,571 babies were born last year. Demand for medical care for pet animals has also risen. As of Feb. 29, there were 5,773 veterinarians in Taiwan, 3,993 of whom were for pet animals, statistics from the Animal and Plant Health Inspection Agency showed. In 2022, the nation had 3,077 pediatricians. As of last
XINJIANG: Officials are conducting a report into amending an existing law or to enact a special law to prohibit goods using forced labor Taiwan is mulling an amendment prohibiting the importation of goods using forced labor, similar to the Uyghur Forced Labor Prevention Act (UFLPA) passed by the US Congress in 2021 that imposed limits on goods produced using forced labor in China’s Xinjiang region. A government official who wished to remain anonymous said yesterday that as the US customs law explicitly prohibits the importation of goods made using forced labor, in 2021 it passed the specialized UFLPA to limit the importation of cotton and other goods from China’s Xinjiang Uyghur region. Taiwan does not have the legal basis to prohibit the importation of goods